Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.

被引：0
|
作者：
Ozaka, Masato
Sasaki, Takashi
Kataoka, Seita
Kanata, Ryo
Ishigaki, Kazunaga
Yamada, Ikuhiro
Matsuyama, Masato
Takano, Koichi
Sasahira, Naoki
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
[2] Canc Inst Hosp JFCR, Tokyo, Japan
[3] Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
[4] Univ Tokyo, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.467
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
467
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study
    Servetto, Alberto
    Santaniello, Antonio
    Napolitano, Fabiana
    Foschini, Francesca
    Marciano, Roberta
    Cascetta, Priscilla
    Amato, Anna Rita
    Augurio, Maria Rosaria
    Maresca, Lucia
    De Placido, Pietro
    De Placido, Sabino
    Formisano, Luigi
    Bianco, Roberto
    [J]. FUTURE ONCOLOGY, 2022, 18 (21) : 2643 - 2654
  • [2] EFFICACY OF MODIFIED FOLFIRINOX AS SECOND-LINE CHEMOTHERAPY IN METASTATIC PANCREATIC ADENOCARCINOMA AFTER GEMCITABINE PLUS NAB-PACLITAXEL FAILURE
    Ikezawa, Kenji
    Kiyota, Ryosuke
    Takada, Ryoji
    Imai, Toshihiro
    Yutaro, Abe
    Fukutake, Nobuyasu
    Takatoshi, Nawa
    Katayama, Kazuhiro
    Ohkawa, Kazuyoshi
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S527 - S527
  • [3] Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
    Portal, Alix
    Pernot, Simon
    Tougeron, David
    Arbaud, Claire
    Bidault, Anne Thirot
    de la Fouchardiere, Christelle
    Hammel, Pascal
    Lecomte, Thierry
    Dreanic, Johann
    Coriat, Romain
    Bachet, Jean-Baptiste
    Dubreuil, Olivier
    Marthey, Lysiane
    Dahan, Laetitia
    Tchoundjeu, Belinda
    Locher, Christophe
    Lepere, Celine
    Bonnetain, Franck
    Taieb, Julien
    [J]. BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 989 - 995
  • [4] Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
    Alix Portal
    Simon Pernot
    David Tougeron
    Claire Arbaud
    Anne Thirot Bidault
    Christelle de la Fouchardière
    Pascal Hammel
    Thierry Lecomte
    Johann Dréanic
    Romain Coriat
    Jean-Baptiste Bachet
    Olivier Dubreuil
    Lysiane Marthey
    Laetitia Dahan
    Belinda Tchoundjeu
    Christophe Locher
    Céline Lepère
    Franck Bonnetain
    Julien Taieb
    [J]. British Journal of Cancer, 2015, 113 : 989 - 995
  • [5] Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma
    Ozaka, Masato
    Sasaki, Takashi
    Yamada, Ikuhiro
    Kanata, Ryo
    Akiyama, Dai
    Katagiri, Tomoko
    Takano, Koichi
    Matsuyama, Masato
    Sasahira, Naoki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [6] Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
    Vivaldi, Caterina
    Fornaro, Lorenzo
    Caparello, Chiara
    Falcone, Alfredo
    Vasile, Enrico
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (11) : e8 - e8
  • [7] Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
    Caterina Vivaldi
    Lorenzo Fornaro
    Chiara Caparello
    Alfredo Falcone
    Enrico Vasile
    [J]. British Journal of Cancer, 2016, 114 : e8 - e8
  • [8] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [9] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    [J]. World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [10] Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
    Pernot, Simon
    Bachet, Jean-Baptiste
    Portal, Alix
    Taieb, Julien
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (11) : e9 - e9
12345